Alternative TAVR access approaches, courtesy of Interventional Cardiology Review 2018;13(3):145–50.
Researchers examined data from eight different studies, noting that transcaval TAVR appears to be a "viable alternative" when transfemoral access is not an option. The procedure was linked to an overall success rate of 98.5%.
At one academic center, reviewing a questionnaire related to body MRI orders resulted in many ordering providers doing an about-face regarding the necessity of their inpatient request.
Image courtesy of the World Heart Federation. Click here to view the original X/Twitter post.
“I am proud of this award, particularly because it represents Mount Sinai’s worldwide scientific contributions and dedication to advancements in the cardiovascular field,” Fuster said.
Based in Seoul, South Korea, Lunit called the acquisition a “significant milestone” in its “mission to conquer cancer" through artificial intelligence.